HER2 as a target in invasive urothelial carcinoma

We evaluated primary tumors from two cohorts, Spain (N = 111) and Greece (N = 102), for patients who were treated with platinum-based chemotherapy. Patients were tested for HER2 status (IHC score of 3+ or FISH ratio of ≥2.2) by immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), D...

Descripción completa

Detalles Bibliográficos
Autores principales: Bellmunt, Joaquim, Werner, Lillian, Bamias, Aristotle, Fay, André P, Park, Rachel S, Riester, Markus, Selvarajah, Shamini, Barletta, Justine A, Berman, David M, de Muga, Silvia, Salido, Marta, Gallardo, Enrique, Rojo, Federico, Guancial, Elizabeth A, Bambury, Richard, Mullane, Stephanie A, Choueiri, Toni K, Loda, Massimo, Stack, Edward, Rosenberg, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472207/
https://www.ncbi.nlm.nih.gov/pubmed/25720673
http://dx.doi.org/10.1002/cam4.432